Ova­Science and Ac­tive Biotech name new CEOs, Valeant adds John Paul­son to the board

 Ova­Science strug­gled hard last year, drop­ping its CEO, COO and 30% of its staff. Now they have named a new CEO, Christo­pher Kroeger. Kroeger pre­vi­ous­ly spent over a decade at the ven­ture firm The Au­ro­ra Funds, and be­fore that he ran Car­dioxyl, which was sold to Bris­tol-My­ers in 2015 for its heart fail­ure drug. Co-founder and Chair­man Michelle Dipp, who stepped in to helm the com­pa­ny dur­ing its tur­bu­lence, is now tak­ing an ad­vi­so­ry role with the fer­til­i­ty com­pa­ny.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.